suprafenacine

Known as: 4,5,6,7-tetrahydro-1H-indazole-3-carboxylic acid (1p-tolyl-meth-(E)-ylidene)hydrazide 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2006-2018
0120062018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
OBJECTIVES Our previous in vitro study showed that 5-(3, 4, 5-trimethoxybenzoyl)-4-methyl-2-(p-tolyl) imidazol (BZML) is a novel… (More)
Is this relevant?
2014
2014
Microtubules are a highly validated target in cancer therapy. However, the clinical development of tubulin binding agents (TBA… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2011
2011
The imido titanium phthalocyanine complex [PcTi(NDip)] (Dip = 2,6-diisopropylphenyl) 2a was synthesized from [PcTiO] 1 and one eq… (More)
Is this relevant?
2007
2007
1-((R)-5-tert-Butyl-indan-1-yl)-3-isoquinolin-5-yl-urea (A-778317) is a novel, stereoselective, competitive antagonist that… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
2006
2006
The diphosphinoketenimine ligand in the neutral complexes fac-[MnI(CO)(3){(PPh(2))(2)C=C=NR}] (1 a: R = Ph; 1 b: R = p-tolyl… (More)
Is this relevant?